Logo Cepheid
Demande de renseignements
Emplacement/Langue

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

{{initials}}
Main Menu
Emplacement/Langue

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Demande de renseignements
Demande de renseignements

Xpert® Norovirus

Order Now
Norovirus computer generated depiction.

Fast detection of Norovirus GI & GII with results available in 90 minutes

Le besoin

an ill woman listens to a physician
  • Norovirus is highly contagious and is the most common cause of acute gastroenteritis worldwide1.2
  • Globally, an estimated 685 million cases of norovirus are seen annually, including 200 million cases amongst children under 51.2
  • Norovirus causes an estimated 200 000 deaths per year, including 50 000 child deaths1.2
  • Every year, this virus is estimated to cost $60 billion worldwide due to healthcare costs and lost productivity1.2
  • Norovirus outbreaks in healthcare institutions require immediate implementation of infection control measures to avoid ward closures1.2
1 Norovirus Burden and trends, CDC https://www.cdc.gov/norovirus/burden.html#worldwide. Consulté 22 novembre 2023.
2 Norovirus introduction. OMS. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/norovirus. Consulté 22 novembre 2023.

La solution

a male and a female researchers scanning cepheid test cartridges
  • Xpert Norovirus detects genotype I (GI) and genotype II (GII), which are responsible for the majority of infections
  • Xpert Norovirus provides rapid results to support timely infection control measures and outbreak response3
  • On-demand identification supports outbreak management enabling fast contact tracing to manage onward transmission4
3 Cleary O, et al. Évaluation du test Xpert Norovirus pour la détection rapide des génogroupes I et II de norovirus dans les échantillons fécaux dans un environnement de laboratoire de routine. British Journal of Biomedical Science. 2017 Dec:74(3):144-147
4 Salmona M, et al. Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilities. Am J Infect Control. 2016 Jun 1;44(6):716-8

L’impact

a smiling female doctor attends an elderly woman
In published implementation studies, Xpert Norovirus PCR testing has been evaluated in routine healthcare settings to assess its potential role in supporting timely laboratory diagnosis. These studies report that fast molecular results may support infection control workflows when used as part of established institutional practices.³ ⁵ ⁶ Across reported study sites, implementation of Xpert Norovirus testing was associated with reduced laboratory turnaround times compared to prior diagnostic approaches under those specific conditions. Reported findings included:
  • An 89% reduction in turnaround time (from 22 hours to 2.4 hours) within the evaluated study settings⁵
  • A reported reduction in unnecessary patient isolation when molecular testing results were incorporated into local infection management decisions⁶
  • Estimated operational cost impacts related to bed availability and isolation practices, as described in site‑specific economic analyses⁶
  • These outcomes reflect observations from published studies conducted in defined healthcare environments and may vary based on institutional workflows, infection control policies, patient populations, and local resource availability.
3 Cleary O, et al. Évaluation du test Xpert Norovirus pour la détection rapide des génogroupes I et II de norovirus dans les échantillons fécaux dans un environnement de laboratoire de routine. British Journal of Biomedical Science. 2017 Dec:74(3):144-147
5 Henningsson AJ, Nilsson Bowers A, Nordgren J, Quttineh M, Matussek A, Haglund S. Rapid diagnosis of acute norovirus-associated gastroenteritis: evaluation of the Xpert Norovirus assay and its implementation as a 24/7 service in three hospitals in Jönköping County, Sweden. Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1867-1871
6 Lyer S, et al. Comparative Evaluation 2 Commercial Norovirus Real-time PCR assays for Hospital Outbreak Management. Federation of Infection society p192 11th-14th Nov. 2013
* 57 minutes with early assay termination for positive results
#values are associated with single site implementation of Xpert Norovirus

Établir une connexion vers de meilleurs résultats

Demande de renseignements

Informations

Get More Insights
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web